{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:03:46Z","timestamp":1788854626367,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177945","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:31:46Z","timestamp":1752568306000},"page":"177945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD"],"prefix":"10.1016","volume":"1003","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6771-6252","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Briand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dubroca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Wettstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Grasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Breyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8291-1489","authenticated-orcid":false,"given":"Claire","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Assaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Broqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Sulpice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejphar.2025.177945_bib1","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1111\/jgh.16726","article-title":"Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake","volume":"39","author":"Aboona","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177945_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but No other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.177945_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114622","article-title":"Glucagon-like peptide 1 agonist and effects on reward behaviour: a systematic review","volume":"283","author":"Badulescu","year":"2024","journal-title":"Physiol. Behav."},{"issue":"25","key":"10.1016\/j.ejphar.2025.177945_bib5","article-title":"Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD","volume":"S0168\u20138278","author":"Barb","year":"2025","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177945_bib6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes. Metabol."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177945_bib7","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jhep.2020.11.045","article-title":"Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease","volume":"74","author":"Boyer-Diaz","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177945_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejphar.2017.11.021","article-title":"Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model","volume":"818","author":"Briand","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177945_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154707","article-title":"Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters","volume":"117","author":"Briand","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177945_bib10","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/s41467-024-47919-9","article-title":"The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis","volume":"15","author":"Cooreman","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177945_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuropharm.2014.06.024","article-title":"PPAR agonists regulate brain gene expression: relationship to their effects on ethanol consumption","volume":"86","author":"Ferguson","year":"2014","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.ejphar.2025.177945_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"NATIVE study group., A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177945_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177945_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3727\/105221617X695519","article-title":"Animal models of alcoholic liver disease: pathogenesis and clinical relevance","volume":"17","author":"Gao","year":"2017","journal-title":"Gene Expr."},{"issue":"22","key":"10.1016\/j.ejphar.2025.177945_bib50","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1074\/jbc.M116.767590","article-title":"The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-\u03b1 agonist-induced amelioration of metabolic disorders in obese mice","volume":"292","author":"Goto","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177945_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.physbeh.2010.07.019","article-title":"Role of caloric homeostasis and reward in alcohol intake in Syrian golden hamsters","volume":"101","author":"Gulick","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2025.177945_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2024.4789","article-title":"Once-Weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial","author":"Hendershot","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ejphar.2025.177945_bib49","doi-asserted-by":"crossref","first-page":"103925","DOI":"10.1016\/j.nsa.2023.103925","article-title":"GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling","volume":"3","author":"Kooij","year":"2024","journal-title":"Neurosci. Appl."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177945_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dom.14890","article-title":"Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses","volume":"25","author":"Kosiborod","year":"2023","journal-title":"Diabetes Obes. Metabol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177945_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1532-0456(01)00205-8","article-title":"Gender difference in enzymes related with alcohol consumption in hamster, an avid consumer of alcohol","volume":"129","author":"Lee","year":"2001","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"issue":"10456","key":"10.1016\/j.ejphar.2025.177945_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","article-title":"Obesity in adults","volume":"404","author":"Lingvay","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177945_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177945_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0091-3057(77)90010-7","article-title":"Failure of signs of physical dependence to develop in hamsters after prolonged consumption of large doses of ethanol","volume":"7","author":"McMillan","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2025.177945_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116331","article-title":"Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist","volume":"173","author":"Moon","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"10431","key":"10.1016\/j.ejphar.2025.177945_bib28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177945_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.amjmed.2019.09.002","article-title":"Atrial fibrillation and heart failure with preserved ejection fraction in patients with nonalcoholic fatty liver disease","volume":"133","author":"Packer","year":"2020","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177945_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tem.2013.03.001","article-title":"A fatty gut feeling","volume":"24","author":"Piomelli","year":"2013","journal-title":"Trends Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177945_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004973","article-title":"Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study","volume":"4","author":"Pisto","year":"2014","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.ejphar.2025.177945_bib34","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s00213-020-05540-w","article-title":"PPAR\u03b3 activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study","volume":"237","author":"Schwandt","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"issue":"17","key":"10.1016\/j.ejphar.2025.177945_bib35","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2024.08.021","article-title":"Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure","volume":"84","author":"Solomon","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ejphar.2025.177945_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.biopsych.2010.12.010","article-title":"Activation of nuclear PPAR\u03b3 receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking","volume":"69","author":"Stopponi","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177945_bib37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cmet.2015.12.008","article-title":"FGF21 regulates sweet and alcohol preference","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab."},{"issue":"716","key":"10.1016\/j.ejphar.2025.177945_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0759","article-title":"Found in translation-Fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)","volume":"15","author":"Wang","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177945_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10741-024-10438-2","article-title":"Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction","volume":"30","author":"Wang","year":"2025","journal-title":"Heart Fail. Rev."},{"issue":"37","key":"10.1016\/j.ejphar.2025.177945_bib43","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.3748\/wjg.v29.i37.5327","article-title":"Efficacy and safety of semaglutide in non-alcoholic fatty liver disease","volume":"29","author":"Zhu","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2025.177945_bib44","doi-asserted-by":"crossref","unstructured":"Said, S., Mukherjee, D., Whayne, T.F., 2016. Interrelationships with metabolic syndrome, obesity and cardiovascular risk. Curr. Vasc. Pharmacol. 14 (5), 415-425. doi:10.2174\/1570161114666160722121615. PMID: 27456105.","DOI":"10.2174\/1570161114666160722121615"},{"key":"10.1016\/j.ejphar.2025.177945_bib45","doi-asserted-by":"crossref","unstructured":"Borlaug, B.A., Jensen, M.D., Kitzman, D.W., Lam, C.S.P., Obokata, M., Rider, O.J., 2023. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc. Res. 118 (18), 3434-3450. doi:10.1093\/cvr\/cvac120. PMID: 35880317; PMCID: PMC10202444.","DOI":"10.1093\/cvr\/cvac120"},{"key":"10.1016\/j.ejphar.2025.177945_bib46","doi-asserted-by":"crossref","unstructured":"Gudenkauf, B., Shaya, G., Mukherjee, M., Michos, E.D., Madrazo, J., Mathews, L., et al., 2024. Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction. J. Cardiol. 83 (2), 100-104. doi:10.1016\/j.jjcc.2023.06.008. PMID: 37364818.","DOI":"10.1016\/j.jjcc.2023.06.008"},{"key":"10.1016\/j.ejphar.2025.177945_bib47","unstructured":"Briand, F., 2010. The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport. Curr. Opin. Investig. Drugs. 11 (3), 289-297. PMID: 20178042."},{"key":"10.1016\/j.ejphar.2025.177945_bib48","unstructured":"Fong, W.P., 1995. Alcohol metabolizing enzymes in the liver and stomach of the hamster. Biochem. Mol. Biol. Int. 35 (1), 197-203. PMID: 7735133."},{"key":"10.1016\/j.ejphar.2025.177945_bib51","doi-asserted-by":"crossref","unstructured":"Mason, B.J., Estey, D., Roberts, A., de Guglielmo, G., George, O., Light, J., et al., 2024. A reverse translational study of PPAR-\u03b1 agonist efficacy in human and rodent models relevant to alcohol use disorder. Neurobiol. Stress. 29, 100604. doi: 10.1016\/j.ynstr.2023.100604. PMID: 38292518; PMCID: PMC10825428.","DOI":"10.1016\/j.ynstr.2023.100604"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:12:15Z","timestamp":1777461135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925006995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S0014299925006995"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177945","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177945"}}